SKFOF:OTC-Sika AG (USD)

COMMON STOCK | Specialty Chemicals |

Last Closing

USD 268

Change

+2.90 (+1.10)%

Market Cap

USD 39.93B

Volume

600.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-29 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap
AIQUY Air Liquide SA ADR

+0.12 (+0.29%)

USD 120.32B
AIQUF L'Air Liquide S.A

+0.32 (+0.15%)

USD 119.70B
GVDNY Givaudan SA ADR

+0.84 (+0.84%)

USD 44.92B
SXYAY Sika AG ADR

+0.04 (+0.13%)

USD 42.45B
GVDBF Givaudan SA

-37.41 (-0.75%)

USD 41.98B
NVZMF Novozymes A/S B

N/A

USD 32.64B
DSFIY DSFIY

-0.01 (-0.09%)

USD 28.66B
DSMFF DSM-Firmenich AG

N/A

USD 28.44B
NPPHY Nippon Paint Holdings Co. Ltd.

+0.07 (+1.84%)

USD 17.49B
SYIEF Symrise AG

N/A

USD 16.28B

ETFs Containing SKFOF

STPX:SW SPDR® MSCI Europe Materi.. 5.77 % 0.00 %

-0.70 (0.00%)

USD 0.28B
CHSRII:SW UBS(Lux)Fund Solutions .. 5.58 % 0.00 %

+0.16 (+0.00%)

N/A
TINT ProShares Smart Materials.. 4.58 % 0.00 %

-0.13 (0.00%)

USD 1.42M
CHSR:XETRA UBS(Lux)Fund Solutions .. 4.54 % 0.00 %

+0.06 (+0.00%)

USD 0.17B
CBCH30:SW 3.90 % 0.00 %

N/A

N/A
FRGG:AU Franklin Global Growth Fu.. 3.50 % 0.00 %

N/A

N/A
SPF1:F SSgA SPDR ETFs Europe II .. 1.08 % 0.00 %

N/A

N/A
ZPRC:F SSgA SPDR ETFs Europe II .. 1.08 % 0.00 %

-0.07 (0.00%)

USD 0.61B
SPF1:XETRA SPDR Refinitiv Global Con.. 1.08 % 0.00 %

-0.04 (0.00%)

N/A
ZPRC:XETRA SPDR Thomson Reuters Glob.. 1.08 % 0.00 %

+0.03 (+0.00%)

N/A
GCVB:SW SPDR Refinitiv Global Con.. 1.08 % 0.00 %

-0.19 (0.00%)

N/A
GCVC:SW SPDR Refinitiv Global Con.. 1.08 % 0.00 %

-0.11 (0.00%)

N/A
EWL iShares MSCI Switzerland .. 0.00 % 0.47 %

+0.28 (+0.00%)

N/A
FLSW Franklin FTSE Switzerland.. 0.00 % 0.09 %

+0.24 (+0.00%)

USD 0.05B
GLCB:LSE SPDR Thomson Reuters Glob.. 0.00 % 0.00 %

N/A

N/A
MTRL:LSE SPDR® MSCI Europe Materi.. 0.00 % 0.00 %

-0.43 (0.00%)

N/A
XSPR:LSE Xtrackers MSCI Europe Mat.. 0.00 % 0.00 %

-57.00 (0.00%)

USD 0.04B
UC93:LSE UBS MSCI Switzerland 20/3.. 0.00 % 0.00 %

+8.50 (+0.00%)

USD 8.25M
UC94:LSE UBS(Lux)Fund Solutions .. 0.00 % 0.00 %

+6.50 (+0.00%)

USD 0.07B
STP:PA SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

-0.25 (0.00%)

USD 0.28B
C030:F Lyxor DJ Switzerland Tita.. 0.00 % 0.00 %

+0.26 (+0.00%)

USD 0.01B
DBXS:F 0.00 % 0.00 %

N/A

N/A
DXS0:F Xtrackers - SLI UCITS ETF 0.00 % 0.00 %

N/A

N/A
DXSC:F Xtrackers Stoxx Europe 60.. 0.00 % 0.00 %

-1.16 (0.00%)

N/A
EXI1:F iShares SLI UCITS ETF (DE.. 0.00 % 0.00 %

+0.20 (+0.00%)

N/A
EXV8:F iShares STOXX Europe 600 .. 0.00 % 0.00 %

N/A

N/A
SPYP:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

-1.05 (0.00%)

N/A
C030:XETRA Amundi Index Solutions - .. 0.00 % 0.00 %

+0.74 (+0.00%)

USD 0.13B
DBXS:XETRA Xtrackers - Switzerland U.. 0.00 % 0.00 %

+0.82 (+0.00%)

USD 1.34B
DXS0:XETRA Xtrackers SLI UCITS ETF 1.. 0.00 % 0.00 %

+1.10 (+0.00%)

USD 0.26B
DXSC:XETRA Xtrackers - Stoxx Europe .. 0.00 % 0.00 %

-0.68 (0.00%)

USD 0.05B
EXI1:XETRA iShares SLI UCITS ETF (DE.. 0.00 % 0.00 %

+0.68 (+0.00%)

USD 0.37B
EXV8:XETRA iShares STOXX Europe 600 .. 0.00 % 0.00 %

-1.03 (0.00%)

USD 0.11B
SPYP:XETRA SPDR® MSCI Europe Materi.. 0.00 % 0.00 %

-0.70 (0.00%)

N/A
1391:TSE 0.00 % 0.00 %

N/A

N/A
CHSPI:SW iShares Core SPI® ETF (C.. 0.00 % 0.00 %

+0.38 (+0.00%)

USD 4.04B
CSSLI:SW iShares SLI® ETF (CH) 0.00 % 0.00 %

+0.50 (+0.00%)

USD 0.67B
CSSMI:SW iShares SMI® ETF (CH) 0.00 % 0.00 %

+0.42 (+0.00%)

USD 2.18B
SLICHA:SW UBS ETF (CH) – SLI® (C.. 0.00 % 0.00 %

-0.05 (0.00%)

USD 32,912.73B
SMICHA:SW UBS ETF (CH) – SMI® (C.. 0.00 % 0.00 %

+0.40 (+0.00%)

USD 17,142.72B
SPICHA:SW UBS ETF (CH) – SPI® (C.. 0.00 % 0.00 %

+0.29 (+0.00%)

USD 131,872.43B
SW2CHA:SW UBS(Lux)Fund Solutions .. 0.00 % 0.00 %

+0.21 (+0.00%)

USD 0.51B
SW2CHB:SW UBS(Lux)Fund Solutions .. 0.00 % 0.00 %

+0.14 (+0.00%)

USD 1.78B
SW2UKD:SW UBS(Lux)Fund Solutions .. 0.00 % 0.00 %

-0.13 (0.00%)

USD 0.05B
SWICHA:SW UBS ETF (CH) – MSCI Swi.. 0.00 % 0.00 %

+0.06 (+0.00%)

USD 226,274.25B
SWUSAH:SW UBS ETF (CH) – MSCI Swi.. 0.00 % 0.00 %

+0.03 (+0.00%)

USD 226,274.21B
XSLI:SW Xtrackers SLI UCITS ETF 1.. 0.00 % 0.00 %

+1.15 (+0.00%)

USD 0.31B
XSMC:SW Xtrackers Switzerland UCI.. 0.00 % 0.00 %

+0.92 (+0.00%)

USD 0.52B
XSMI:SW Xtrackers Switzerland UCI.. 0.00 % 0.00 %

+0.18 (+0.00%)

USD 1.36B
FICS First Trust International.. 0.00 % 0.00 %

+0.16 (+0.00%)

USD 0.21B
CHSRI:SW UBS ETF (CH) - MSCI Switz.. 0.00 % 0.00 %

+0.11 (+0.00%)

N/A
CHEUR:SW 0.00 % 0.00 %

N/A

N/A
CHEURD:SW UBS(Lux)Fund Solutions .. 0.00 % 0.00 %

N/A

N/A
CHSRIA:SW UBS ETF (CH) MSCI Switzer.. 0.00 % 0.00 %

+0.18 (+0.00%)

N/A
CHUSD:SW UBS(Lux)Fund Solutions .. 0.00 % 0.00 %

+0.07 (+0.00%)

N/A
CHUSDD:SW UBS(Lux)Fund Solutions .. 0.00 % 0.00 %

-0.15 (0.00%)

N/A
S2HGBD:SW UBS(Lux)Fund Solutions .. 0.00 % 0.00 %

N/A

USD 0.07B
SMIEX:SW iShares SLI UCITS ETF (DE.. 0.00 % 0.00 %

-0.54 (0.00%)

USD 5,933.96B
SWEUAH:SW UBS ETF (CH) – MSCI Swi.. 0.00 % 0.00 %

N/A

USD 226,274.20B
S2HGBA:SW UBS(Lux)Fund Solutions .. 0.00 % 0.00 %

N/A

USD 8.29M
ASWA:XETRA European Green Deal UCITS.. 0.00 % 0.00 %

-0.01 (0.00%)

USD 9.35M

Market Performance

  Market Performance vs. Industry/Classification (Specialty Chemicals) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 13.28% 67% D+ 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.28% 65% D 63% D
Trailing 12 Months  
Capital Gain -13.78% 42% F 43% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -13.78% 41% F 41% F
Trailing 5 Years  
Capital Gain 51.41% 80% B- 72% C
Dividend Return 8.41% 22% F 19% F
Total Return 59.82% 77% C+ 68% D+
Average Annual (5 Year Horizon)  
Capital Gain 6.15% 66% D+ 54% F
Dividend Return 7.30% 62% D 51% F
Total Return 1.15% 39% F 29% F
Risk Return Profile  
Volatility (Standard Deviation) 29.66% 62% D 71% C-
Risk Adjusted Return 24.60% 71% C- 65% D
Market Capitalization 39.93B 94% A 97% N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.